Specialists testify that Pfizer tampered with study results for epilepsy drug

NEW YORK Experts reviewing documents in a lawsuit against Pfizer said in federal court in Boston Monday that the company manipulated the publication of studies to influence sales of the epilepsy drug Neurontin (gabapentin).

The experts said Pfizer delayed publication of studies that cast doubt on the drug’s efficacy and used spin tactics to downplay negative data.

In a statement Tuesday, Pfizer denied manipulating the data, maintaining that the study results were objective, accurate, balanced and complete.